NASDAQ:BCAC Brookline Capital Acquisition (BCAC) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$9.94▼$27.7450-Day Range$0.36▼$22.7152-Week Range$9.50▼$27.74Volume586,400 shsAverage Volume39,682 shsMarket Capitalization$153.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Brookline Capital Acquisition alerts: Email Address Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> About Brookline Capital Acquisition Stock (NASDAQ:BCAC)Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.Read More Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> BCAC Stock News HeadlinesOctober 8, 2023 | stockhouse.comQuetta Acquisition Corporation Announces Pricing of $60 Million Initial Public OfferingAugust 15, 2023 | finance.yahoo.comQ2 2023 electroCore, Inc. Earnings CallSeptember 9, 2024 | Behind the Markets (Ad)Unveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?May 25, 2023 | seekingalpha.comLFAC LF Capital Acquisition Corp. IIApril 6, 2023 | benzinga.comBrookline Capital Downgrades Oncternal Therapeutics to HoldDecember 30, 2022 | yahoo.comBrookline Bancorp, Inc. Announces Preliminary Results of Merger Consideration Elections Regarding Pending PCSB Financial Corporation MergerAugust 1, 2022 | finance.yahoo.comApexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology CompanyJune 29, 2022 | nz.finance.yahoo.comApexigen Announces Board Appointment and New ChairSeptember 9, 2024 | Behind the Markets (Ad)Unveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?June 8, 2022 | finance.yahoo.comApexigen Appoints William Duke as Chief Financial OfficerMay 9, 2022 | tmcnet.comApexigen to Host Investor Day on Antibody Therapeutic Pipeline and Unique APXiMAB™ PlatformMarch 23, 2022 | benzinga.comBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mount Rainier Acquisition Corp. (Nasdaq - RNER), Brookline Capital Acquisition Corp. (Nasdaq - BCAC), Vickers Vantage Corp. I (Nasdaq - VCKA), Pono Capital Corp (Nasdaq - PONO)March 18, 2022 | seekingalpha.comCancer focused Apexigen to go public via deal with SPAC Brookline CapitalJanuary 24, 2022 | nasdaq.comBrookline Capital Acquisition Corp. Common Stock (BCAC)August 27, 2021 | barrons.comBrookline Capital Acquisition Corp.July 26, 2021 | finance.yahoo.comBrookline Capital Markets Hosts Biotech Symposium TodaySee More Headlines Receive BCAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryN/A Current SymbolNASDAQ:BCAC CUSIPN/A CIK1814140 Webwww.brooklinecapitalacquisitioncorp.com Phone646-643-6716FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-480,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-416.32% Return on Assets-4.75% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.07 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,746,000Free Float5,451,000Market Cap$153.20 million OptionableNot Optionable Beta-0.03 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Samuel P. Wertheimer Ph.D.Chairman & CEOMr. Scott A. Katzmann (Age 66)Pres & Director Mr. Patrick SturgeonChief Financial OfficerKey CompetitorsiTeos TherapeuticsNASDAQ:ITOSExscientiaNASDAQ:EXAIREGENXBIONASDAQ:RGNXProKidneyNASDAQ:PROKAllogene TherapeuticsNASDAQ:ALLOView All Competitors This page (NASDAQ:BCAC) was last updated on 9/9/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredForget polls, focus on these 5 tickersWith all the geopolitical tensions in the world… all the inflation… all the expectations of a new round of Fed...StockEarnings | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brookline Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brookline Capital Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
